Publication

Byline

Location

US Patent Issued to Deciphera Pharmaceuticals on July 21 for "CSF-1R inhibitors and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,672, issued on July 21, was assigned to Deciphera Pharmaceuticals LLC (Waltham, Mass.). "CSF-1R inhibitors and methods of use thereof" was ... और पढ़ें


US Patent Issued to Blueprint Medicines on July 21 for "Pyrimidine compounds, compositions, and medicinal applications thereof" (Indian, American Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,673, issued on July 21, was assigned to Blueprint Medicines Corp. (Cambridge, Mass.). "Pyrimidine compounds, compositions, and medicinal ap... और पढ़ें


US Patent Issued to SHANGHAI ZHIMENG BIOPHARMA on July 21 for "Crystal form of compound represented by formula I, and preparation therefor and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,674, issued on July 21, was assigned to SHANGHAI ZHIMENG BIOPHARMA INC. (Shanghai). "Crystal form of compound represented by formula I, and... और पढ़ें


US Patent Issued to Trevena on July 21 for "Compounds and methods of preparing compounds S1P1 modulators" (North Carolina, Pennsylvania Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,675, issued on July 21, was assigned to Trevena Inc. (Chesterbrook, Pa.). "Compounds and methods of preparing compounds S1P1 modulators" wa... और पढ़ें


US Patent Issued to ALCHEMEDICINE on July 21 for "Compound, endothelin-A receptor antagonist, and pharmaceutical composition" (Japanese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,676, issued on July 21, was assigned to ALCHEMEDICINE INC. (Ibaraki, Japan). "Compound, endothelin-A receptor antagonist, and pharmaceutica... और पढ़ें


US Patent Issued to Corvus Pharmaceuticals on July 21 for "Compounds and methods for modulating interleukin-2-inducible t-cell kinase" (California Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,677, issued on July 21, was assigned to Corvus Pharmaceuticals Inc. (South San Francisco, Calif.). "Compounds and methods for modulating in... और पढ़ें


US Patent Issued to INVENTIVA on July 21 for "Crystal form of Lanifibranor, preparation method therefor, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,678, issued on July 21, was assigned to INVENTIVA (Daix, France). "Crystal form of Lanifibranor, preparation method therefor, and use there... और पढ़ें


US Patent Issued to GUANGZHOU HEALTHQUEST PHARMA, ASCENTAGE PHARMA (SUZHOU) on July 21 for "Crystals of alkynyl-containing compound, salt and solvate thereof, preparation method, and applications" (Chinese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,679, issued on July 21, was assigned to GUANGZHOU HEALTHQUEST PHARMA Co. LTD. (China) and ASCENTAGE PHARMA (SUZHOU) Co. LTD. (China). "Crys... और पढ़ें


US Patent Issued to Neurocrine Biosciences on July 21 for "Substituted pyrazolo[1,5-Alphapyrimidines as CRF receptor antagonists" (California Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,680, issued on July 21, was assigned to Neurocrine Biosciences Inc. (San Diego). "Substituted pyrazolo[1,5-Alphapyrimidines as CRF receptor... और पढ़ें


US Patent Issued to PrimeGene (Beijing) on July 21 for "Process for the preparation of 2-{3-[3-amino-4-(7H-pyrrolo[2,3-dpyrimidin-4-yl)-1H-pyrazol-1-yl-1-(isopropylsulfonyl)azetidin-3-yl}acetonitrile" (Chinese Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,686,681, issued on July 21, was assigned to PrimeGene (Beijing) Co. Ltd. (Beijing). "Process for the preparation of 2-{3-[3-amino-4-(7H-pyrrolo... और पढ़ें